SEATTLE, WA / ACCESS Newswire / May 22, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares ...
SEATTLE, WA / / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ...
Treasure Global (TGL) announced that it will effect a 1-for-20 reverse stock split of its common stock, par value $0.00001 per share. Treasure Global’s Common Stock will continue to trade on the ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback